• Skin and Hair Care
  • Beauty Advices
  • Mental Health
  • Medical News
Womens Secret Portal
for beauty bloggers
Beauty Advices

IMS: Fezolinetant’s improvements in sleep quality, hot flashes as early as week 4

by admin October 4, 2026
written by admin October 4, 2026

Women struggling with the disruptive effects of menopause may find relief much sooner than expected thanks to new real world data regarding the nonhormonal medication fezolinetant. Findings presented at the 20th World Congress on Menopause by the International Menopause Society reveal that patients experienced significant improvements in hot flashes and night sweats as early as four weeks into treatment. These results come from a preliminary analysis of the OPTION VMS study, which tracked women aged 40 to 75 receiving various nonhormonal therapies in routine clinical settings.

Beyond just reducing heat flashes, the drug showed a powerful impact on one of the most debilitating aspects of menopause: sleep deprivation. Researchers used a combination of patient reports and medical grade wearable devices to track rest patterns, finding that participants saw substantial gains in sleep efficiency and fewer nighttime awakenings starting at the fourth week. By the twelfth week of treatment, some users reported an average reduction of two point six nighttime awakenings compared to where they started. This is particularly significant given that up to sixty percent of menopausal women suffer from sleep disturbances, often waking frequently due to intense night sweats.

Dr. Marla Shapiro of the University of Toronto emphasized how reassuring it was to see objective data from wearables align perfectly with what patients were reporting subjectively. She noted that because hot flashes and insomnia have such a far reaching impact on a woman’s daily quality of life and general well being, having concordant evidence of improvement provides strong validation for the treatment’s efficacy in a real world environment outside of tightly controlled trials.

From a technical standpoint, fezolinetant works as a selective neurokinin 3 receptor antagonist, essentially blocking specific signals in the brain to help stabilize the body’s internal thermostat located in the hypothalamus. Throughout the observation period, these benefits remained steady through twelve weeks without any new safety concerns emerging during the preliminary analysis. While some mild liver enzyme elevations were noted in two rare cases, neither resulted in a patient needing to stop their medication, suggesting a favorable profile for those seeking alternatives to hormone replacement therapy.

0 comment
0
FacebookTwitterPinterestEmail
admin

previous post
2026 International Food Information Council Food & Health Survey: A Focus On Food & Ingredient Safety
next post
Does sleep affect athletic performance? What young athletes and parents should know

You may also like

Sound Waves May Be the Secret to Better...

November 20, 2026

Your Gait May Be a Secret Window Into...

November 19, 2026

Your Midday Snooze Could Be a Warning Sign...

November 18, 2026

The Hidden Link Between Your Pillow and Your...

November 17, 2026

The Sleep Paradox: Why Your Cannabis Habit Might...

November 16, 2026

The Nightly Brain Wash Slows Down With Age

November 15, 2026

The Hidden Cost of a Good Night’s Rest:...

November 14, 2026

Why Your Midnight Snack Might Be Doing More...

November 13, 2026

Why Your Wake Up Time Matters More Than...

November 12, 2026

Why Your Nightcap Is Actually Sabotaging Your Rest

November 11, 2026
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Contacts
  • Email Whitelisting
  • Privacy Policy
  • Terms and Conditions

Copyright © 2026 WomensSecretPortal.com All Rights Reserved.


Back To Top
Womens Secret Portal
  • Skin and Hair Care
  • Beauty Advices
  • Mental Health
  • Medical News